960 related articles for article (PubMed ID: 34378982)
1. Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein.
Ragotte RJ; Pulido D; Donnellan FR; Hill ML; Gorini G; Davies H; Brun J; McHugh K; King LDW; Skinner K; Miura K; Long CA; Zitzmann N; Draper SJ
mSphere; 2021 Aug; 6(4):e0064721. PubMed ID: 34378982
[TBL] [Abstract][Full Text] [Related]
2. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells.
Wang K; Chen W; Zhang Z; Deng Y; Lian JQ; Du P; Wei D; Zhang Y; Sun XX; Gong L; Yang X; He L; Zhang L; Yang Z; Geng JJ; Chen R; Zhang H; Wang B; Zhu YM; Nan G; Jiang JL; Li L; Wu J; Lin P; Huang W; Xie L; Zheng ZH; Zhang K; Miao JL; Cui HY; Huang M; Zhang J; Fu L; Yang XM; Zhao Z; Sun S; Gu H; Wang Z; Wang CF; Lu Y; Liu YY; Wang QY; Bian H; Zhu P; Chen ZN
Signal Transduct Target Ther; 2020 Dec; 5(1):283. PubMed ID: 33277466
[TBL] [Abstract][Full Text] [Related]
3. No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor.
Shilts J; Crozier TWM; Greenwood EJD; Lehner PJ; Wright GJ
Sci Rep; 2021 Jan; 11(1):413. PubMed ID: 33432067
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2.
Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
Cells; 2021 Jun; 10(6):. PubMed ID: 34201214
[TBL] [Abstract][Full Text] [Related]
5. Tumor markers as an entry for SARS-CoV-2 infection?
Xia P; Dubrovska A
FEBS J; 2020 Sep; 287(17):3677-3680. PubMed ID: 32738184
[TBL] [Abstract][Full Text] [Related]
6. A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody.
Scheim DE
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269703
[TBL] [Abstract][Full Text] [Related]
7. CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement.
Ulrich H; Pillat MM
Stem Cell Rev Rep; 2020 Jun; 16(3):434-440. PubMed ID: 32307653
[TBL] [Abstract][Full Text] [Related]
8. TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein.
Kishimoto M; Uemura K; Sanaki T; Sato A; Hall WW; Kariwa H; Orba Y; Sawa H; Sasaki M
Viruses; 2021 Feb; 13(3):. PubMed ID: 33671076
[TBL] [Abstract][Full Text] [Related]
9. Possible inhibition of GM-CSF production by SARS-CoV-2 spike-based vaccines.
Li J; Wang P; Tracey KJ; Wang H
Mol Med; 2021 May; 27(1):49. PubMed ID: 34022793
[TBL] [Abstract][Full Text] [Related]
10. Relevance of VEGF and CD147 in different SARS-CoV-2 positive digestive tracts characterized by thrombotic damage.
Bortolotti D; Simioni C; Neri LM; Rizzo R; Semprini CM; Occhionorelli S; Laface I; Sanz JM; Schiuma G; Rizzo S; Varano G; Beltrami S; Gentili V; Gafà R; Passaro A
FASEB J; 2021 Dec; 35(12):e21969. PubMed ID: 34822202
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 spike protein receptor-binding domain N-glycans facilitate viral internalization in respiratory epithelial cells.
Zheng L; Ma Y; Chen M; Wu G; Yan C; Zhang XE
Biochem Biophys Res Commun; 2021 Nov; 579():69-75. PubMed ID: 34592572
[TBL] [Abstract][Full Text] [Related]
12. Sequestration of membrane cholesterol by cholesterol-binding proteins inhibits SARS-CoV-2 entry into Vero E6 cells.
Kulma M; Šakanović A; Bedina-Zavec A; Caserman S; Omersa N; Šolinc G; Orehek S; Hafner-Bratkovič I; Kuhar U; Slavec B; Krapež U; Ocepek M; Kobayashi T; Kwiatkowska K; Jerala R; Podobnik M; Anderluh G
Biochem Biophys Res Commun; 2024 Jul; 716():149954. PubMed ID: 38704887
[TBL] [Abstract][Full Text] [Related]
13. CD147 as an alternative binding site for the spike protein on the surface of SARS-CoV-2.
Faghihi H
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):11992-11994. PubMed ID: 33336782
[No Abstract] [Full Text] [Related]
14. CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma.
Geng J; Chen L; Yuan Y; Wang K; Wang Y; Qin C; Wu G; Chen R; Zhang Z; Wei D; Du P; Zhang J; Lin P; Zhang K; Deng Y; Xu K; Liu J; Sun X; Guo T; Yang X; Wu J; Jiang J; Li L; Zhang K; Wang Z; Zhang J; Yan Q; Zhu H; Zheng Z; Miao J; Fu X; Yang F; Chen X; Tang H; Zhang Y; Shi Y; Zhu Y; Pei Z; Huo F; Liang X; Wang Y; Wang Q; Xie W; Li Y; Shi M; Bian H; Zhu P; Chen ZN
Signal Transduct Target Ther; 2021 Sep; 6(1):347. PubMed ID: 34564690
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of the potential interaction of SARS-CoV-2 spike protein to CD147 in COVID-19 associated-lymphopenia.
Helal MA; Shouman S; Abdelwaly A; Elmehrath AO; Essawy M; Sayed SM; Saleh AH; El-Badri N
J Biomol Struct Dyn; 2022 Feb; 40(3):1109-1119. PubMed ID: 32936048
[TBL] [Abstract][Full Text] [Related]
16. A Recombinant Fragment of Human Surfactant Protein D Binds Spike Protein and Inhibits Infectivity and Replication of SARS-CoV-2 in Clinical Samples.
Madan T; Biswas B; Varghese PM; Subedi R; Pandit H; Idicula-Thomas S; Kundu I; Rooge S; Agarwal R; Tripathi DM; Kaur S; Gupta E; Gupta SK; Kishore U
Am J Respir Cell Mol Biol; 2021 Jul; 65(1):41-53. PubMed ID: 33784482
[TBL] [Abstract][Full Text] [Related]
17. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.
Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S
Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993
[TBL] [Abstract][Full Text] [Related]
18. The spike protein of SARS-CoV-2 induces heme oxygenase-1: Pathophysiologic implications.
Singh RD; Barry MA; Croatt AJ; Ackerman AW; Grande JP; Diaz RM; Vile RG; Agarwal A; Nath KA
Biochim Biophys Acta Mol Basis Dis; 2022 Mar; 1868(3):166322. PubMed ID: 34920080
[TBL] [Abstract][Full Text] [Related]
19. Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.
Puray-Chavez M; LaPak KM; Schrank TP; Elliott JL; Bhatt DP; Agajanian MJ; Jasuja R; Lawson DQ; Davis K; Rothlauf PW; Liu Z; Jo H; Lee N; Tenneti K; Eschbach JE; Shema Mugisha C; Cousins EM; Cloer EW; Vuong HR; VanBlargan LA; Bailey AL; Gilchuk P; Crowe JE; Diamond MS; Hayes DN; Whelan SPJ; Horani A; Brody SL; Goldfarb D; Major MB; Kutluay SB
Cell Rep; 2021 Jul; 36(2):109364. PubMed ID: 34214467
[TBL] [Abstract][Full Text] [Related]
20. Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates.
Kang YF; Sun C; Zhuang Z; Yuan RY; Zheng Q; Li JP; Zhou PP; Chen XC; Liu Z; Zhang X; Yu XH; Kong XW; Zhu QY; Zhong Q; Xu M; Zhong NS; Zeng YX; Feng GK; Ke C; Zhao JC; Zeng MS
ACS Nano; 2021 Feb; 15(2):2738-2752. PubMed ID: 33464829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]